Applied BioCode Corporation
Applied BioCode Corporation (TAI: 6598) is trading at NT$26.65, about ₹80 at today's TWD/INR rate, as of 1 Oct 2026, 1:30 AM ET, down 2.74% today. Applied BioCode is not currently available to trade on Paasa; this page shows its price, statistics and the Indian tax treatment for information.
Quote
Today's low
NT$26.25
Today's high
NT$27.20
52 week low
NT$20.50
52 week high
NT$31.90
6598 opened at NT$26.85, closed previously at NT$27.40, and has traded between NT$20.50 and NT$31.90 over the past 52 weeks.
About
Applied BioCode Corporation specializes in the complete lifecycle—from design and development to manufacturing and commercialization—of multiplex diagnostic testing solutions tailored for the In-Vitro Diagnostics (IVD) market. Among its key offerings are two sophisticated systems: the BioCode MDx 3000, an automated molecular diagnostics platform that streamlines PCR amplification, hybridization, and detection steps; and the BioCode 2500 analyzer, specifically engineered to read barcoded magnetic beads (BMBs) and display their unique identification along with fluorescence intensity. The company also boasts an extensive portfolio of diagnostic assays, including the BioCode SARS-CoV-2 Assay, a high-throughput, automated nucleic acid multiplex test for detecting SARS-CoV-2 genetic material in nasopharyngeal swabs. Other panels comprise BioCode Respiratory Pathogen Panels, capable of simultaneously identifying and differentiating seventeen distinct respiratory pathogens in nasopharyngeal samples, and BioCode gastrointestinal (GI) pathogen panels, which target prevalent GI pathogens such as viruses, bacteria, and parasites responsible for infectious diarrheal diseases. An expanding pipeline of MDx assays for various molecular tests is also under development. Beyond these, Applied BioCode provides specialized reagents like analyte-specific reagents for fungal pathogens, and multiplex kits for human cytokines and chemokines, vital for biomarker identification. For research flexibility, they offer premixed and customizable multiplex kits for mouse models, alongside similar cytokine/chemokine multiplex kits for rat, monkey, canine, and non-human primate studies. Rounding out its comprehensive services, the company supplies its proprietary BMBs, calibration beads, and coupling kits for a wide array of bioassay applications. They also offer ELISA (Enzyme-Linked Immunosorbent Assay), a method for the precise quantification of drug, protein, or antibody levels in biological samples such as cell lysates or serum, in addition to providing full-spectrum assay development services. Applied BioCode Corporation is headquartered in Santa Fe Springs, California.
Key statistics
Avg. volume
332.48K
Market cap
NT$2.74B
P/E Ratio
-55.52
Price-to-sales ratio
4.11
Enterprise value
NT$1.85B
Free cash flow yield
-10.43%
Debt-to-equity ratio
0.07
Return on equity
-31.28%
ROIC
-24.07%
Beta
0.63
Dividend yield
0.00%
Last dividend
NT$0.00
Financial overview
Revenue
NT$475.20M
Earnings per share
-NT$1.96
Free cash flow
-NT$235.46M
Net profit margin
-7.33%
Gross margin
62.27%
EBITDA
-NT$166.96M
Revenue growth
38.52%
Similar securities
This is not an investment recommendation
Applied BioCode for Indian investors
Applied BioCode is listed on the Taiwan Stock Exchange. It is not currently available to trade on Paasa; the figures on this page are for information, and the tax notes below apply to Indian residents who hold it.
Taxes on Applied BioCode for Indian residents
Trading and limits
- Trading hours
- 9:00 am – 1:30 pm SGT
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneApplied BioCode does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
FAQs
Can I buy Applied BioCode on Paasa?
Applied BioCode (6598) has been listed on the Taiwan Stock Exchange since 2017, in the Medical - Devices industry. Applied BioCode is not currently available to trade on Paasa; the figures on this page are for information. Indian residents who hold it through another broker still declare it under the rules below.
How much does one Applied BioCode share cost in rupees?
One Applied BioCode share is NT$26.65 — about ₹80 at a TWD/INR rate of 3.01 on 30 Sep 2026. Both the Applied BioCode price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for investing abroad from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability.
How are gains on Applied BioCode shares taxed in India?
Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the TWD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Applied BioCode price.
Does Applied BioCode pay a dividend?
No. Applied BioCode does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one: dividends are taxed at your slab rate in India.
When does TAI trade, in Indian time?
The Taiwan Stock Exchange trades 6:30 am – 11:00 am IST in Indian time.
Is Applied BioCode a Taiwan company, and does that change how it is taxed?
Applied BioCode trades on the Taiwan Stock Exchange in TWD, but the company is domiciled in Cayman Islands. Applied BioCode trades as an ordinary share listed directly in Taiwan, not a depositary receipt. Your India-side capital-gains treatment is the same either way.
Do I have to declare Applied BioCode shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. The holding is reported with its cost and its closing value.
Does the rupee rate affect what I make on Applied BioCode?
Yes. Applied BioCode is priced in TWD, so your rupee outcome combines the TWD move with the TWD/INR move between the day you remit and the day you convert back.